Boothbay Fund Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-30,000
Closed -$293K 2275
2025
Q3
$293K Buy
+30,000
New +$231K ﹤0.01% 1467
2025
Q1
Sell
-62,002
Closed -$877K 1699
2024
Q4
$859K Buy
+62,002
New +$978K 0.02% 689
2021
Q2
Sell
-48,162
Closed -$1.21M 2061
2021
Q1
$1.21M Sell
48,162
-77,087
-62% -$1.45M 0.05% 507
2020
Q4
$1.5M Buy
+125,249
New +$1.48M 0.06% 349
2019
Q2
Sell
-20,000
Closed -$205K 866
2019
Q1
$243K Buy
+20,000
New +$250K 0.02% 562

Other funds holding PRTA

Boothbay Fund Management's PRTA Position: Q4 2025 in Review

Boothbay Fund Management sold out of Prothena Corp (PRTA) in Q4 2025, closing a stake of 30,000 shares — an estimated $293K sold.

Boothbay Fund Management first reported a position in PRTA in Q1 2019 and held it in 5 quarters. The position peaked at $1.5M in Q4 2020. 181 funds tracked by Wall St. Rank hold PRTA as of Q4 2025.

  • Boothbay Fund Management reported no remaining Prothena Corp position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 30,000 Prothena Corp shares in Q4 2025, an estimated $293K.
  • Boothbay Fund Management first reported a position in Prothena Corp in Q1 2019 and held it in 5 quarters.
  • Boothbay Fund Management's Prothena Corp position peaked at $1.5M in Q4 2020.
  • 181 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.